Global Blood Therapeutics is dedicated to improving the care of people living with Sickle Cell Disease, a rare or orphan disease affecting primarily the black community.
RIESTER RX developed a successful unbranded disease awareness and education campaign for Global Blood Therapeutics while also supporting branded initiatives to promote the novel treatment for Sickle Cell, Oxbryta.